Avi Biopharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Avi Biopharma Inc
TickerSRPT
CIK #0000873303
CUSIP803607100
SectorLife Sciences - Pharmaceutical Preparations
Address3450 Monte Villa Parkway Suite 101, Bothell, WA 98021
Source [EDGAR]
CIK Filing 2011 - 2024
[0000873303] 10-K
[0000873303] 10-Q
[0000873303] 3
[0000873303] 4
[0000873303] 5
[0000873303] 8-K
[0000873303] D
[0000873303] SC 13D
[0000873303] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Sands Capital Management LLC Sarepta Therapeutics Inc [2022-02-14] 6.16
Janus Henderson Group PLC Sarepta Therapeutics Inc [2022-02-11] 8.3
Sands Capital Management LLC Sarepta Therapeutics Inc [2021-02-16] 1.24
Capital Research Global Investors Sarepta Therapeutics Inc [2021-02-10] 0.8
Sands Capital Management LLC Sarepta Therapeutics Inc [2020-02-14] 6.1
Price T Rowe Associates Inc /MD/ Sarepta Therapeutics Inc [2019-02-14] 6.1
FMR LLC Sarepta Therapeutics Inc [2018-02-09] 0.0
Capital Ventures International Sarepta Therapeutics Inc [2017-12-21] 5.4
Tourbillon Capital Partners LP Sarepta Therapeutics Inc [2016-10-28] 6.2
Sabby Management LLC Sarepta Therapeutics Inc [2016-05-06] 5.15
FMR LLC Sarepta Therapeutics Inc [2016-02-12] 0.0
Barry Richard Sarepta Therapeutics Inc [2015-05-05] 7.66
Point72 Asset Management LP Sarepta Therapeutics Inc [2015-05-01] 5.3
Point72 Asset Management LP Sarepta Therapeutics Inc [2014-04-30] 5.2
Perceptive Advisors LLC Sarepta Therapeutics Inc [2014-02-14] 0.45
Susquehanna Capital Group Sarepta Therapeutics Inc [2014-02-13] 5.2
Vanguard Group Inc Sarepta Therapeutics Inc [2014-02-11] 5.48
Columbia Wanger Asset Management LLC Sarepta Therapeutics Inc [2014-02-06] 7.0
BlackRock Inc Sarepta Therapeutics Inc [2014-01-30] 6.7
Sabby Management LLC Sarepta Therapeutics Inc [2013-04-24] 5.26
[2012-11-19] None
Form 3/4/5 Filer 2011 - 2024
Brown Ryan Edward
Sarepta Therapeutics, Inc.
Arif Bilal
Rodino-Klapac Louise
Estepan Ian Michael
Behrens M Kathleen
Barry Richard
Mayo Stephen
Boor Kathryn Jean
Chambers Michael Andrew
Nicaise Claude
Wigzell Hans Lennart Rudolf
Ciambrone William
Gray Mary Ann
Ingram Douglas S
O'Neill Gilmore Neil
Martin John C
Bratica Joseph
Mahatme Sandesh
Howton David T
Bonney Michael W
Cumbo Alexander
Ruff Shamim
Basi Guriqbal S.
Kaye Edward M. MD
Stehman-Breen Catherine
Wood Joan
Aphale Jayant
Price Ben Gil
Goolsbee William Alden
Kress Jean-Paul
Hodgman John
Christopher Nishan Garabedian
Chase Anthony R
Krieg Arthur M
Martignetti Anthony
Jacobsen Michael A
Form 13F Holdings
Firm Period DFND Voting Shares
Vanguard Group Inc [2023-03-31] SOLE 0.0 7,988,211.0
BlackRock Inc. [2023-03-31] SOLE 5,035,008.0 5,282,569.0
Janus Henderson Group PLC [2023-03-31] DFND 0.0 4,908,204.0
Avoro Capital Advisors LLC [2023-03-31] SOLE 3,900,000.0 3,900,000.0
JPMorgan Chase & Co [2023-03-31] DFND 3,313,951.0 3,702,345.0
EcoR1 Capital LLC [2023-03-31] SOLE 2,999,453.0 2,999,453.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 2,933,612.0
FMR LLC [2023-03-31] DFND 2,637,360.0 2,644,656.0
Bank of New York Mellon Corp [2023-03-31] DFND 1,632,367.0 1,855,876.0
State Street Corp [2023-03-31] DFND 1,598,314.0 1,773,976.0
Susquehanna International Group LLP [2023-03-31] DFND 139,827.0 1,348,027.0
Geode Capital Management LLC [2023-03-31] DFND 1,261,971.0 1,261,971.0
Pictet Asset Management Sa [2023-03-31] DFND 1.0 1,213,356.0
Casdin Capital LLC [2023-03-31] SOLE 1,185,000.0 1,185,000.0
Two Sigma Advisers LP [2023-03-31] SOLE 1,070,234.0 1,175,734.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 224,500.0 1,123,923.0
Two Sigma Investments LP [2023-03-31] SOLE 1,097,143.0 1,097,143.0
Deutsche Bank AG [2023-03-31] DFND 899,581.0 1,000,121.0
Citadel Advisors LLC [2023-03-31] DFND 992,114.0 992,114.0
Goldman Sachs Group Inc [2023-03-31] DFND 897,979.0 986,872.0
American Century Companies Inc [2023-03-31] DFND 953,204.0 953,204.0
OrbiMed Advisors LLC [2023-03-31] DFND 82,900.0 940,100.0
Farallon Capital Management LLC [2023-03-31] OTR 913,300.0 913,300.0
Morgan Stanley [2023-03-31] DFND 805,021.0 889,506.0
Sands Capital Management LLC [2023-03-31] SOLE 652,481.0 874,765.0
D. E. Shaw & Co., Inc. [2023-03-31] DFND 849,337.0 851,737.0
Federated Hermes Inc [2023-03-31] DFND 816,886.0 816,922.0
Renaissance Technologies LLC [2023-03-31] SOLE 764,020.0 806,478.0
Westfield Capital Management Co LP [2023-03-31] SOLE 661,244.0 802,658.0
Boxer Capital, LLC [2023-03-31] OTR 775,000.0 775,000.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com